Start for free
Start for free
Verition Fund Management logo

Verition Fund Management

North America, Connecticut, United States, Greenwich

Description

Verition Fund Management operates as a multi-strategy and multi-manager investment platform.

Investor Profile

Verition Fund Management has made 13 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (31%)
  • Series C (31%)
  • Series F (8%)
  • Post Ipo Equity (8%)
  • Series A (8%)
  • Series Unknown (8%)
  • Series D (8%)

Country Focus

  • United States (69%)
  • China (15%)
  • Ireland (8%)
  • India (8%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Life Science
  • Health Care
  • Medical
  • Therapeutics
  • Biopharma
  • Neuroscience
  • Alternative Medicine
  • Precision Medicine
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Verition Fund Management frequently co-invest with?

Surveyor Capital
Surveyor Capital
North America, Illinois, United States, Chicago
Co-Investments: 4
CA
Cormorant Asset Management
North America, Massachusetts, United States, Boston
Co-Investments: 3
Eventide
Eventide
North America, Massachusetts, United States, Boston
Co-Investments: 4
Alexandria Venture Investments
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 3
aMoon Fund
aMoon Fund
Asia, HaMerkaz, Israel, Ra'anana
Co-Investments: 2
RTW Investments
RTW Investments
North America, New York, United States, New York
Co-Investments: 2
RA Capital Management
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 3
Deerfield
Deerfield
North America, New York, United States, New York
Co-Investments: 2
Marshall Wace
Marshall Wace
Europe, England, United Kingdom, London
Co-Investments: 2
Rock Springs Capital
Rock Springs Capital
North America, Maryland, United States, Baltimore
Co-Investments: 2

Which angels does Verition Fund Management often collaborate with?

BT
Belinda Termeer
North America, Massachusetts, United States, Marblehead
Shared Deals: 1

What are some of recent deals done by Verition Fund Management?

Evommune

Palo Alto, California, United States

Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.

BiotechnologyHealth CareLife Science
Series COct 31, 2024
Amount Raised: $115,000,000
Georgiamune

Gaithersburg, Maryland, United States

Georgiamune is a biotechnology company developing next-generation immunotherapeutics for cancer and autoimmune diseases.

BiotechnologyHealth CareTherapeutics
Series AAug 9, 2023
Amount Raised: $75,000,000
Alebund Pharmaceuticals

Shanghai, Shanghai, China

Alebund Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases.

BiotechnologyLife SciencePharmaceutical
Series CApr 12, 2023
Amount Raised: $29,091,755
Korro Bio

Cambridge, Massachusetts, United States

Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.

BiotechnologyHealth CarePharmaceutical
Series BJan 5, 2022
Amount Raised: $116,000,000
BYJU'S

Bangalore, Karnataka, India

BYJU'S is an educational technology company that develops personalized learning programs for K-12 students.

E-LearningEdTechEducation
Series FOct 4, 2021
Amount Raised: $362,061,161
Alebund Pharmaceuticals

Shanghai, Shanghai, China

Alebund Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases.

BiotechnologyLife SciencePharmaceutical
Series BSep 13, 2021
Amount Raised: $54,500,000
LEXEO Therapeutics

New York, New York, United States

LEXEO Therapeutics utilizes gene therapy to treat genetically defined cardiovascular and central nervous system diseases.

BiotechnologyLife ScienceTherapeutics
Series BSep 9, 2021
Amount Raised: $100,000,000
Vedanta Biosciences

Cambridge, Massachusetts, United States

Vedanta Biosciences creates microbiome-derived therapies to address immune and infectious diseases by modulating the gut microbiota.

BiotechnologyBusiness DevelopmentMedical
Series DJul 21, 2021
Amount Raised: $68,000,000
Amylyx Pharmaceuticals

Cambridge, Massachusetts, United States

Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.

BiotechnologyMedicalNeurosciencePharmaceutical
Series CJul 20, 2021
Amount Raised: $135,000,000
Larimar Therapeutics

Bala Cynwyd, Pennsylvania, United States

Larimar Therapeutics is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases.

BiotechnologyMedicalTherapeutics
Post Ipo EquityMay 21, 2021
Amount Raised: $95,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator